RHHBY(RHHBY)
RHHBY
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $62.91B | $65.49B | $68.69B | $72.90B | $76.00B |
| Low | $60.72B | $62.94B | $66.42B | $70.49B | $73.49B |
| High | $66.68B | $69.42B | $72.60B | $77.05B | $80.32B |
| EBITDA Avg | $20.54B | $21.39B | $22.43B | $23.80B | $24.82B |
| Low | $19.83B | $20.55B | $21.69B | $23.02B | $24.00B |
| High | $21.77B | $22.67B | $23.71B | $25.16B | $26.23B |
| EBIT Avg | $16.90B | $17.59B | $18.45B | $19.58B | $20.41B |
| Low | $16.31B | $16.91B | $17.84B | $18.93B | $19.74B |
| High | $17.91B | $18.65B | $19.50B | $20.70B | $21.58B |
| Net Income Avg | $16.18B | $17.38B | $18.84B | $21.29B | $23.30B |
| Low | $15.64B | $16.33B | $18.03B | $20.38B | $22.30B |
| High | $16.72B | $18.47B | $20.23B | $22.87B | $25.02B |
| EPS Avg | $2.52 | $2.70 | $2.93 | $3.31 | $3.63 |
| Low | $2.43 | $2.54 | $2.81 | $3.17 | $3.47 |
| High | $2.60 | $2.87 | $3.15 | $3.56 | $3.90 |
| Analysts (Rev / EPS) | 10 / 5 | 10 / 5 | 4 / 2 | 5 / 1 | 5 / 1 |
| Metric | Q2 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $15.92B | $12.55B |
| Low | $15.77B | $12.44B |
| High | $16.06B | $12.67B |
| EBITDA Avg | $5.20B | $4.10B |
| Low | $5.15B | $4.06B |
| High | $5.24B | $4.14B |
| EBIT Avg | $4.27B | $3.37B |
| Low | $4.24B | $3.34B |
| High | $4.31B | $3.40B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 2 / — |